To study the effect of Unani drug in the treatment of patients with Chronic obstructive pulmonary disease.
Phase 2
Completed
- Conditions
- Health Condition 1: null- Chronic Obstructive Pulmonary Disease (COPD)Health Condition 2: J449- Chronic obstructive pulmonary disease, unspecified
- Registration Number
- CTRI/2018/02/012180
- Lead Sponsor
- Jamia Hamdard
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Known Moderate cases of COPD based on Gold Criteria defined by WHO.
Patients who are willing to participate
Exclusion Criteria
Patients aged less than 18 years
Patients having acute exacerbation of breathlessness
Patients having severe or very severe COPD.
patients taking β-blockers/ACE inhibitors
Patients suffering from Diabetes Mellitus, Hepatic Failure, Renal Failure, Congestive Heart Failure.
Pregnant and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method